Masimo | MASI - Debt


Masimo reported $642.2M in Debt for its fiscal quarter ending in June of 2025.





Debt Change Date
Abbott USD 12.94B 496M Sep/2025
Align Technology USD 121.27M 1.75M Sep/2025
AtriCure USD 77.25M 15.39M Jun/2025
Avanos Medical USD 137.3M 29.9M Jun/2025
Baxter International USD 9.73B 584M Jun/2025
Becton, Dickinson and Co. USD 19.18B 160M Sep/2025
Boston Scientific USD 12.05B 19M Sep/2025
Dexcom USD 2.45B 132.5M Sep/2025
Edwards Lifesciences USD 702.6M 3.2M Jun/2025
General Electric Aerospace USD 20.49B 344M Dec/2025
Globus Medical USD 121.1M 120.63M Jun/2025
Haemonetics USD 1.22B 416.99M Jun/2025
Insulet USD 1.4B 295.7M Jun/2025
Integra LifeSciences USD 2.01B 170.48M Jun/2025
Intuitive Surgical USD 0 0 Mar/2025
Masimo USD 642.2M 299.4M Jun/2025
Medtronic USD 28.61B 93M Jun/2025
Owens Minor USD 1.95B 91.18M Mar/2025
ResMed USD 846.35M 178.06M Sep/2025
Steris USD 2.06B 10.4M Sep/2025
Stryker USD 14.86B 1.74B Dec/2025
Tandem Diabetes Care USD 449.01M 94.67M Jun/2025
Teleflex USD 2B 180.08M Jun/2025
Thermo Fisher Scientific USD 35.68B 451M Sep/2025
Zimmer Biomet Holdings USD 8.11B 540.1M Sep/2025